Bausch Health reports Q2 non-GAAP EPS of $1.26, exceeding expectations by $0.25, with revenue up 12.6% year-over-year.
Bausch Health Companies posted Q2 non-GAAP earnings per share of $1.26, beating estimates by $0.25. Revenue reached $2.85 billion, a 12.6% year-over-year increase, surpassing expectations by $190 million.
The company’s performance reflects stronger-than-anticipated growth, with prior-year revenue at $2.53 billion. Analysts had projected revenue of $2.66 billion and EPS of $1.01 for the quarter.
Bausch Health also raised its full-year guidance for revenue, adjusted EBITDA, and adjusted earnings, excluding Bausch + Lomb.